NHS England

What NHS England does

NHS England is a statutory public body established under the Health and Social Care Act 2012, operating as the headquarters of the NHS in England and accountable to Parliament through the Department of Health and Social Care. It commissions and oversees healthcare delivery for the entire population of England — approximately 55 million people — through a national network of more than 200 NHS trusts, 6,000+ GP practices, 11,500+ community pharmacies, and 42 integrated care boards. Its core mission is to improve health outcomes, reduce waiting times, and address health inequalities across primary care, hospital services, mental health, community health, and public health programmes.

The organization's digital infrastructure is anchored by the NHS App (14 million monthly active users, up 83% since January 2023) as the consumer front door and the Federated Data Platform (86% acute trust adoption) as the operational data backbone, built on Microsoft Azure and Palantir's Foundry infrastructure. AI and digital tools are deployed at material scale: Microsoft 365 Copilot across 505,000 clinical and administrative staff (~£120M contract), AI-assisted chest X-ray analysis across roughly half of trusts (reporting times cut from 8 to 4 days), AI demand forecasting on FDP, and autonomous triage tools (Rapid Health, Flok Health) covering 3M+ patients. Other major products include NHS Online (8.5M virtual appointments planned), Single Patient Record, Community Diagnostic Centres, Virtual Wards, Martha's Rule patient safety initiative, and the Health Data Research Service (a forthcoming independent data gateway co-funded with Wellcome).

NHS England is funded entirely through general taxation via annual government grant-in-aid, with services free at point of use. The NHS 2025/26 budget includes approximately £26 billion in additional annual investment, supplemented by ring-fenced allocations for CDCs (£237M), community pharmacy expansion (£340M), and AI diagnostics (£20M). The organization is statutorily independent but operationally a government instrument: it has no commercial revenue, no shareholders, and no pricing model in the commercial sense. Following the April 2023 merger with NHS Digital and Health Education England, the organization is now slated for abolition by April 2027 under the proposed NHS Modernisation Bill, with functions transferring back to the Department of Health and Social Care — creating material structural uncertainty around the entity's medium-term operating model.

Name

NHS England

Legal name

NHS England

Website

https://england.nhs.uk

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

NHS England is a statutory public body that commissions and oversees NHS healthcare services for England's 55 million residents, operating the NHS App, Federated Data Platform, and a national network of trusts and GP practices, funded entirely through UK government taxation.

Ownership category

akta.pro rank

Product category

Public Healthcare Administration

NAICS

Public Administration (92), General Medical and Surgical Hospitals (6221), Hospitals (622), Executive, Legislative, and Other General Government Support (921)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000), Services-Hospitals (8060)

akta.pro primary industry

Public Health Policy, Planning & Governance (BPAIAJAB)

akta.pro secondary industries

State/Provincial Health Department & Public Health Administration (BPAIABAH), Immunization & Vaccination Programs Administration (BPAIAJAD), Health Regulation, Licensing & Compliance (Public Health) (BPAIAJAN)

Keywords

• Public healthcare services
• National health commissioning
• Digital health platforms
• Preventive health programmes
• Population health management

Headquarters

HQ city

Redditch

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Government Funding: NHS England is funded through annual government allocations from the Department of Health and Social Care. Funding is determined through the NHS mandate and covers the entire population of England. The NHS budget for 2025/26 includes approximately £26 billion in additional annual NHS investment. The NHS also receives funding through specific initiatives such as the £20 million AI Diagnostic Fund and £237 million for community diagnostic centres.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels7 records

Core offering

NHS England leads, commissions and oversees the National Health Service in England, delivering universal publicly-funded healthcare to the entire resident population. It operates national digital platforms (the NHS App and the Federated Data Platform), runs national screening and vaccination programmes, commissions hospital, primary care, community and mental health services through 200+ NHS trusts and 6,000+ GP practices, and sets strategic direction for the health system. The organisation is funded by general taxation via the Department of Health and Social Care.

Product overview

NHS England operates a portfolio of interconnected digital platforms and healthcare programmes. The core NHS App serves as the primary consumer-facing portal with 14+ million monthly active users, enabling prescription management, appointment booking, and NHS communications. The NHS Federated Data Platform (FDP) provides the underlying data infrastructure connecting patient records across trusts for operational management and AI-powered analytics. Supporting programmes include NHS Online for virtual consultations, the Single Patient Record initiative for unified medical histories, Community Diagnostic Centres for decentralized testing, Virtual Wards for hospital-at-home care, and national screening programmes for bowel, breast, and cervical cancers. Patient safety initiatives include Martha's Rule enabling rapid second opinions. The Health Data Research Service is under development to accelerate medical research. The portfolio reflects the 'hospital to community' and 'analogue to digital' shifts in NHS England's 10 Year Health Plan.

Differentiator

Problem solved

Functional benefit

Products and services

• NHS App Primary consumer-facing digital platform of the NHS in England, enabling patients to order repeat prescriptions, book GP appointments, view test results, access NHS communications and use integrated AI triage tools. Reached 14 million monthly active users and is the digital front door for the population of England.
• NHS Federated Data Platform (FDP) Central data integration platform connecting patient records across NHS trusts for waiting-list management, appointment allocation and treatment personalisation. Hosts AI tools including assisted theatre scheduling, triage support via the Demand Centre, AI-assisted discharge summaries, and A&E demand forecasting.
• NHS Online Virtual appointment service providing triage through the NHS App and video consultations with specialists across England, scaling the NHS's outpatient capacity through digital channels.
• NHS 111 Telephone and online urgent care triage service that directs patients to appropriate care settings. Updated triage protocols automatically treat sudden collapse during sport as requiring immediate CPR following the Adam Ankers inquest findings.
• Community Diagnostic Centres (CDCs) Network of diagnostic facilities delivering MRI, CT, ultrasound and other tests closer to patients' homes. Supported by £237 million of government investment and integrated with NHS England's wider elective-recovery and early-diagnosis strategies.
• Bowel Cancer Screening Programme National screening programme distributing home Faecal Immunochemical Test (FIT) kits for bowel cancer screening. Partnership with GXO Logistics, MAST (the world's largest FIT distributor) and RDi delivers kits directly to patients' homes.
• Virtual Wards Hospital-at-home service that delivers acute care, monitoring and clinical support to patients in their own homes as an alternative to inpatient admission, supported by remote-monitoring technology and dedicated operational bulletins.
• Martha's Rule Patient safety programme allowing hospital patients and families to request an independent rapid clinical review via a dedicated helpline. Implemented across 143 NHS sites in England and credited with saving more than 500 lives since September 2024.
• Single Patient Record Initiative to create a unified patient record across England by mandating that all NHS providers share data, enabling clinicians to access a patient's full medical history regardless of treatment location. Expected to reduce 20,000 A&E visits annually and prevent 6,000 hospital admissions.
• Health Data Research Service (HDRS) Secure research gateway providing access to linked primary care, hospital, prescribing and mortality data, research-ready cohort datasets, advanced diagnostics including genomics, and faster clinical-trial data integration. Being established as an independent organisation co-funded by NHS England, DHSC and Wellcome.
• NHS Shared Business Services Construction Frameworks Procurement framework managed by NHS Shared Business Services for public-sector construction works across the UK and Crown Dependencies, covering minor works up to £5 million, intermediate works £5-15 million and major works above £15 million.
• NHS Digital Academy Training and development programme for current and aspiring digital leaders across the NHS, delivering learning opportunities, news, events and professional development resources for health-technology leadership.
• NHS Vaccination Programmes National immunisation programmes covering HPV, MMR, COVID-19, meningitis B and routine childhood immunisations, delivered through NHS sites, pharmacies, schools and community settings including targeted catch-up campaigns.

Quantifiable outcome

• 7.22 million total waiting list in May 2026, with 65.3% of patients treated within 18 weeks by end of March - first time crossing 65% threshold since November 2021
• +5 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability12 records

Feature6 records

Partnerships

20 partnerships are on record, tiered core and minor.

• SanoficoreStrategic or Co-development Partner · 23 June 2026Developer of teplizumab (tzield), world's first drug to delay onset of type 1 diabetes, approved for NHS use in England and Wales by NICE. Immunotherapy can postpone symptomatic disease for up to three years.
• MHRA (Medicines and Healthcare products Regulatory Agency)coreStrategic or Co-development Partner · 14 June 2026MHRA partnered with NHS England (London) and London Health Innovation Networks to launch 'London Region I' regulatory sandbox for AI-enabled medical devices in NHS settings. Up to 10 AI medical device manufacturers selected for initial phase.
• London Health Innovation NetworkscoreStrategic or Co-development Partner · 14 June 2026Partnership with MHRA and NHS England (London) for regulatory sandbox enabling AI-enabled medical devices to be safely tested in real-world NHS settings.
• MicrosoftcoreTechnology or Integration · 8 June 2026Microsoft providing Microsoft 365 Copilot AI tools to 505,000 NHS staff following successful pilot. Contract valued at approximately £120 million. Deployment includes Copilot Studio for custom AI agent development. Pilot showed 43 minutes daily time savings per worker.
• MSDcoreStrategic or Co-development Partner · 8 June 2026MSD manufacturer of pembrolizumab (Keytruda) approved by NHS England for aggressive cervical cancer. Commercial deal enabled NHS launch following NICE approval. Clinical trials showed 68% progression-free at 2 years vs 57% with chemoradiotherapy alone.
• AbbViecoreStrategic or Co-development Partner · 3 June 2026Manufacturer of mirvetuximab soravtansine (Elahere), first new drug for platinum-resistant ovarian cancer in over 20 years. NHS England approved following positive NICE evaluation with up to 400 women per year eligible.
• GRAILminorStrategic or Co-development Partner · 30 May 2026NHS-Galleri trial completed with 142,250 participants aged 50-77 in England. Trial showed 14% reduction in Stage IV cancer diagnoses and four-fold increase in cancer detection. GRAIL submitted FDA premarket approval application supported by NHS trial data.
• Rapid HealthcoreTechnology or Integration · 20 April 2026AI-powered Smart Triage tool integrated into NHS App enabling over a million patients to book GP appointments directly. Used by 200+ GP practices covering 3 million patients across 31 ICBs.
• Department for Transport and DfTminorStrategic or Co-development Partner · 31 March 2026DWP £3.5 million pilot programme backed NHS musculoskeletal waiting list reduction achieving 20% reduction across 17 areas. Programme assessed 7,500 patients through digital tools and one-day clinics.
• GXO LogisticscoreStrategic or Co-development Partner · 30 March 2026GXO Logistics appointed as managed service provider for national bowel cancer home testing kit (FIT kits) distribution across England. Partnership with MAST (world's largest FIT distributor) and RDi (diagnostic kitting partner) supporting shift from hospitals to community settings.
• MASTcoreChannel Partner/ Reseller/ Distributor · 30 March 2026World's largest FIT distributor partnered with GXO Logistics and NHS England for bowel cancer screening kit distribution across England.
• RDicoreChannel Partner/ Reseller/ Distributor · 30 March 2026UK's leading end-to-end diagnostic kitting partner working with GXO Logistics and NHS England for bowel cancer screening programme.
• Flok HealthcoreTechnology or Integration · 10 February 2026AI-powered physiotherapy clinic expanded across 11 NHS regions covering 2.4 million patients. Pilot more than halved waiting lists for back pain and reduced musculoskeletal waiting times by 44% in under 10 weeks.
• AtoscoreImplementation/ SI/ Consulting Partner · 10 February 2026Atos serves as Delivery Partner in NHS England's Blueprinting Programme, helping drive productivity gains through EPR optimization and responsible AI implementation.
• National Academy for Social PrescribingminorStrategic or Co-development Partner · 1 December 2025Partnership report urging NHS to strengthen partnerships with faith groups across England, identifying them as underused resource addressing deprivation, loneliness, and poor mental health.
• Good Faith PartnershipminorStrategic or Co-development Partner · 1 December 2025Co-produced report with National Academy for Social Prescribing recommending £1 billion National Community Health and Wellbeing Fund and greater faith community involvement in neighbourhood health planning.
• NHS Blood and Transplant (NHSBT)coreStrategic or Co-development Partner · 15 February 2025NHSBT collects plasma donations across UK for Octapharma to manufacture plasma-derived medicines. Over 250,000 litres of plasma collected and shipped for fractionation, with finished products now being distributed to NHS hospitals.
• Palantir TechnologiescoreTechnology or Integration · 1 November 2023Palantir's £330m Federated Data Platform contract awarded in 2023 to consolidate and manage patient data across NHS. Platform connects patient records, manages waiting lists, and allocates appointments. Government considering early termination at spring 2027 break clause.
• OctapharmacoreStrategic or Co-development Partner · 1 January 2023Octapharma selected as fractionator to process UK-donated plasma into plasma-derived medicines. NHS BT supplies over 250,000 litres of plasma for manufacture of immunoglobulin and albumin treatments.
• IBMcoreTechnology or Integration · 1 January 2022IBM partnered with NHS England in 2022 to modernize NHS App digital healthcare services. Monthly active users rose 83% to 14 million, while public cloud costs per user fell 50%, saving £55,000 per month since March 2024 and approximately £660,000 annually.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Optum (UnitedHealth Group): US health-services and innovation subsidiary of UnitedHealth Group, operating 90,000+ employed/affiliated providers and the largest US health-data platform. Comparable to NHS England's FDP ambitions as a population-scale health data and analytics operator, though embedded in a commercial insurance-led model.
• Ascension Health: US Catholic non-profit health system operating 140+ hospitals across 19 states. Comparable in large-scale hospital delivery and digital transformation (it has run its own EHR/analytics modernisation), but US-anchored and faith-based rather than universal-coverage.
• HCA Healthcare: One of the largest for-profit hospital operators in the US, with 190+ hospitals and 2,400+ care sites. Comparable in acute-care delivery scale to the NHS hospital network, but operates on a commercial model serving insured patients rather than as a universal public system.
• Kaiser Permanente: US-based integrated managed-care consortium with 12.5M+ members, combining insurer and provider functions across 40+ hospitals. Comparable in integrated-care and population-health ambitions (electronic health records, AI deployment at scale) to NHS England's integrated care boards, though US-anchored.
• U.S. Department of Veterans Affairs (Veterans Health Administration): The largest integrated healthcare system in the US, providing care to 9M+ veterans through 1,200+ facilities. Comparable to NHS England as a government-operated national health system with universal-coverage-style entitlement, large-scale digital infrastructure (Cerner EHR), and population health mandate — though disease-burden profile and political structure differ.
• CommonSpirit Health: One of the largest US non-profit health systems, operating 140+ hospitals and 2,200+ care sites across 24 states. Comparable in scale and non-profit, mission-driven operating model, though structured as a multi-state private system rather than a national public service.

Others

• Centers for Medicare & Medicaid Services (CMS): US federal agency administering Medicare, Medicaid, and CHIP — covering 150M+ Americans. Comparable to NHS England in scale of public healthcare financing and population coverage, but acts primarily as payer/regulator rather than direct provider.

Direct peers

• UK Health Security Agency (UKHSA): UK government agency responsible for public health protection, including vaccination programmes and pandemic preparedness. Comparable in public-health policy and immunisation programme administration to NHS England's vaccination and screening functions.
• NHS Scotland (NHS Scotland Health and Social Care Directorate): The publicly funded health service for Scotland, operating under the same universal-coverage model as NHS England but administered by the Scottish Government. Directly comparable in mission, funding model, and population-scale delivery, but with a smaller population (~5.5M) and devolved governance.
• NHS Wales (Welsh Government Health and Social Services): The publicly funded health service for Wales, similarly structured as a national universal-coverage system. Directly comparable in operating model, but smaller scale (~3.1M population) and devolved under Welsh Government.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nhsengland
• YouTubeyoutube.com/thenhsengland
• Facebookfacebook.com/NHSEngland
• LinkedInlinkedin.com/company/2786868
• Instagraminstagram.com/nhsengland

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments16 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NHS England